Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation.
Saved in:
| Title: | Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. |
|---|---|
| Authors: | Abdelmonem, Rehab1, Al-Samadi, Inas Essam Ibrahim1, El Nashar, Rasha M.2, Jasti, Bhaskara R.3, El-Nabarawi, Mohamed A.4 Mohamed.elnabarawi@pharma.cu.edu.eg |
| Source: | Drug Delivery. Dec2022, Vol. 29 Issue 1, p2868-2882. 15p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
